Patent ID: 8551987

Claim:
Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate sulphate (3), characterised in that in the X-ray powder diagram it has, inter alia, the characteristic values d=20.53 Å, 8.97 Å, 6.04 Å, 5.76 Å, 5.27 Å, 5.19 Å, 5.02 Å, 4.82 Å, 4.74 Å, 4.32 Å, 3.80 Å, 3.74 Å and 3.70 Å.